Novel Agents and Combinations in Hodgkin Lymphoma
0 Visninger
• 07/09/23
0
0
Indlejre
administrator
Abonnenter
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer